skip to Main Content
New Trial Announced By Biogen

New trial announced by Biogen

New Clinical Study Planned to Evaluate the Potential Benefit of an Investigational Higher Dose of Nusinersen in People with SMA Previously Treated with Evrysdi® (risdiplam)

You can read the full details by clicking here

Back To Top